ScreenPoint Medical

ScreenPoint Medical develops artificial intelligence software for breast imaging, including Transpara, to assist radiologists in reading digital breast tomosynthesis and mammography. The company focuses on deep learning and image analysis for automated interpretation of breast scans, leveraging large curated image databases and an understanding of mammography physics and clinical deployment. Its technology aims to improve early cancer detection, increase diagnostic consistency, and reduce unnecessary recalls, helping physicians screen for breast cancer earlier and enable less invasive treatment options.